Cimavax

The CIMAvax vaccine trial is for people with stage IIIB or IV non-small cell lung cancer (NSCLC) who have been treated previously by one line of chemotherapy.

To find out if you may qualify for the study, click "begin."

Begin

* In order to protect your personal health information, if we call you and someone else answers the phone, or the call goes to your voicemail, we will not identify ourselves as calling from Roswell Park Cancer Institute, unless you give us permission in advance to do that.

Please note: Your answers for this question are simply used for research purposes and will not be a factor in your eligibility.

Unfortunately you are not eligible for this study based on your answer to this question. If you selected incorrectly, you may change your answer; however, a clinician will validate these answers before you can enroll in any study. If you’d like information on other clinical trials for NSCLC, please visit the links below.

NSCLC clinical trials at Roswell Park

ClinicalTrials.gov